
TRANSPORT multicenter trial in cancer patients with septic shock finds liberal transfusion offers no lactate or survival benefit but increases thrombosis
AI-summarized from the linked source. Educational brief, not medical advice.
Brief summary
The 18-center TRANSPORT randomized trial of 187 cancer patients with septic shock found that a liberal transfusion strategy (Hb threshold 9.0 g/dL) did not improve 12-hour lactate clearance (52% vs 50%) or 28-day survival over a restrictive strategy (Hb threshold 7.0 g/dL), but increased thrombotic events from 1% to 13%.
What NurseJet pulled from the source
Septic shock carries high mortality among oncology patients, in whom severe anemia frequently prompts clinician concern regarding systemic tissue hypoxia. The multicenter TRANSPORT superiority randomized trial, conducted across 18 intensive care units in France, evaluated whether an early liberal red blood cell transfusion threshold (hemoglobin target 9.0 g/dL, n=93) improved tissue perfusion compared to a restrictive threshold (hemoglobin target 7.0 g/dL, n=94) during the initial 48 hours of resuscitation in adult cancer patients with septic shock (baseline lactate > 2.0 mmol/L and Hb < 9.0 g/dL). The trial was stopped prematurely for safety concerns after enrolling 187 of a planned 260 patients. Twelve-hour lactate reduction (normalization <= 2.0 mmol/L or >= 30% decrease) showed no difference between arms (52% liberal vs 50% restrictive; odds ratio 1.07; 95% CI 0.60 to 1.90; P = 0.82). Arterial or venous thrombotic complications occurred significantly more often in the liberal group (13% vs 1%; P = 0.001), while 28-day mortality remained comparable (46% liberal vs 53% restrictive; P = 0.34).
Why this matters for nurses
Bedside critical care nurses frequently administer blood transfusions in septic shock and monitor for complications. These findings reinforce that higher hemoglobin targets do not accelerate shock resolution even in high-risk oncology patients, and alert nurses to the substantial thrombotic hazard of unneeded liberal transfusions.
Bedside takeaway
In cancer patients with septic shock, liberal transfusion (Hb <9 g/dL) did not improve lactate clearance or 28-day survival over restrictive transfusion (Hb <7 g/dL) but raised thrombotic complications from 1% to 13%.
Key takeaways
- Multicenter randomized trial in 18 French ICUs evaluated transfusion thresholds during initial 48 hours of septic shock in cancer patients.
- Trial halted prematurely at 187 patients due to safety imbalances between study arms.
- Liberal transfusion (Hb < 9.0 g/dL) failed to improve 12-hour lactate clearance (52% vs 50%, P = 0.82) or 28-day mortality (46% vs 53%, P = 0.34).
- Liberal transfusion was associated with a marked increase in arterial and venous thrombotic events (13% vs 1%, P = 0.001).
Practice implications
- Adhere strictly to restrictive transfusion thresholds (hemoglobin < 7.0 g/dL) during septic shock resuscitation unless provider orders or institutional protocol dictate otherwise, and maintain heightened surveillance for deep vein thrombosis or arterial occlusion if liberal transfusions are administered.
Limitations & cautions
- Premature termination resulted in underpowered final sample size (187 enrolled of 260 planned); conducted exclusively within French intensive care units; limited to adult hematologic and solid oncology patients.
- AI-summarized from the linked source. Review the original article before applying to practice.
Citations
Exact source links
Public citations are filtered to exact credible source pages. Homepage-only or invalid links stay in admin review and are not shown here.
Intensive care medicine (PubMed)
Intensive care medicine (PubMed). Early red blood cell transfusion strategy in septic shock among patients with cancer: the TRANSPORT randomized controlled trial.
https://pubmed.ncbi.nlm.nih.gov/42616082/
Professional education only


